Autolus Therapeutics plc (NASDAQ: AUTL)
| Pre-Market | Intra-Day | After-Hours |
|---|---|---|
| 1.55 (0.00 / 0.00%) | 1.49 (-0.04 / -2.61%) | 1.51 (+0.02 / +1.34%) |
| 31-Jul 09:20 | 31-Jul 16:00 | 31-Jul 17:08 |
Sector: Healthcare || Industry: Biotechnology
| Previous Close | 1.53 | Year Low | 1.18 |
| Open | 1.51 | Year High | 2.52 |
| Day Low | 1.47 | Price Avg 50 | 1.57 |
| Day High | 1.55 | Price Avg 200 | 1.54 |
| Volume | 713.99 K | Market Cap | 396.55 M |
News
| Symbol | Catalyst News |
|---|---|
| AUTL | Autolus Therapeutics: Navigating A Bumpy 2026 Seeking Alpha | 2026-07-22 10:51:11 3 Cancer Stocks to Watch as Oncology Innovation Accelerates Zacks Investment Research | 2026-07-08 09:35:14 Autolus Therapeutics (AUTL) Could Find a Support Soon, Here's Why You Should Buy the Stock Now Zacks Investment Research | 2026-06-10 10:56:08 Autolus Therapeutics PLC Sponsored ADR (AUTL) Just Flashed Golden Cross Signal: Do You Buy? Zacks Investment Research | 2026-06-01 10:56:20 Autolus Therapeutics plc (AUTL) Q1 2026 Earnings Call Transcript Seeking Alpha | 2026-05-14 20:10:43 Autolus Therapeutics Q1 Earnings Call Highlights MarketBeat | 2026-05-14 10:09:50 |
Analysis
| Symbol | 1D | 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|---|---|
| AUTL | -2.61 | -2.61 | -6.88 | 5.67 | 8.76 | -37.92 |
Earnings
| Date | Time | Symbol | company_name | Period | Metric | Estimate | Actual | Surprise | YrAgo | Growth | sector_industry |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/14/2026 | BMO | AUTL | Autolus Therapeutics | Q1 2026 | EPS | -0.26 | -0.27 | -3.85 | -0.26 | -3.80 | |
| 05/14/2026 | BMO | AUTL | Autolus Therapeutics | Q1 2026 | REV | 26.16 M | 26.22 M | 0.22 | 8.98 M | 191.89 | |
| 03/27/2026 | BMO | AUTL | Autolus Therapeutics | Q4 2025 | EPS | -0.27 | -0.34 | -25.93 | -0.09 | -277.80 | |
| 03/27/2026 | BMO | AUTL | Autolus Therapeutics | Q4 2025 | REV | 24.48 M | 24.29 M | -0.78 | 0.00 | ||
| 11/12/2025 | BMO | AUTL | Autolus Therapeutics | Q3 2025 | EPS | -0.23 | -0.30 | -30.43 | -0.31 | 3.20 | |
| 11/12/2025 | BMO | AUTL | Autolus Therapeutics | Q3 2025 | REV | 21.31 M | 21.19 M | -0.55 | |||
| 08/12/2025 | BMO | AUTL | Autolus Therapeutics | Q2 2025 | EPS | -0.23 | -0.18 | 21.74 | -0.22 | 18.20 | |
| 08/12/2025 | BMO | AUTL | Autolus Therapeutics | Q2 2025 | REV | 12.91 M | 20.92 M | 62.13 | 0.00 |
Outlooks
| Date | Time | Symbol | Company | Period | Metric | Estimate | Outlook | Previous | Catalyst | list_link | eps_est | rev_est | cur_midpoint | pre_midpoint | Growth * | yrago_growth | pre_growth | company_sector | company_industry | ref_id | chart_code | history_code | sector_industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/14/2026 | 07:00 AM | AUTL | Autolus Therapeutics | FY 2026 | REV | $130.06 M | $120.00 M ~ $135.00 M | 0.00 | 127.50 | -1.97 | 47,182 |
Ratings
| Date | Symbol | Analyst Firm | Rating Current | Rating Previous | Analyst Action |
|---|---|---|---|---|---|
| 05/14/2026 | AUTL | HC Wainwright & Co. | Buy | Buy | Maintain |
| 04/09/2026 | AUTL | Needham | Buy | Buy | Maintain |
| 03/31/2026 | AUTL | Mizuho | Outperform | Outperform | Maintain |
| 03/27/2026 | AUTL | Needham | Buy | Buy | Maintain |
| 01/12/2026 | AUTL | Needham | Buy | Buy | Maintain |
Dividends
| Date | Symbol | Company | Type | Value | Yield | Record Date | Exch Date | Pay Date | Notes |
|---|
Sign-Up to see the full list of CATALYSTS in the Calendars
